ACM
ADAR1 Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.4M | Buy |
948,069
+8,400
| +0.9% | +$464K | 8.04% | 2 |
|
|
2025
Q1 | $45.4M | Sell |
939,669
-80,664
| -8% | -$3.9M | 8.44% | 1 |
|
|
2024
Q4 | $39.4M | Buy |
1,020,333
+39,038
| +4% | +$1.51M | 7.87% | 2 |
|
|
2024
Q3 | $44.2M | Sell |
981,295
-622,637
| -39% | -$28M | 7.18% | 2 |
|
|
2024
Q2 | $55.6M | Buy |
1,603,932
+818,277
| +104% | +$28.4M | 10.49% | 1 |
|
|
2024
Q1 | $22.7M | Buy |
785,655
+584,796
| +291% | +$16.9M | 5.16% | 4 |
|
|
2023
Q4 | $4.61M | Buy |
+200,859
| New | +$4.61M | 1.65% | 14 |
|